UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057826
Receipt number R000066101
Scientific Title The Second Meal Effect of Different Types of Snacking
Date of disclosure of the study information 2025/05/10
Last modified on 2025/05/10 15:03:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Second Meal Effect of Different Types of Snacking

Acronym

The Second Meal Effect of Different Types of Snacking

Scientific Title

The Second Meal Effect of Different Types of Snacking

Scientific Title:Acronym

The Second Meal Effect of Different Types of Snacking

Region

Japan


Condition

Condition

lifestyle disease

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to exprore changes in post-dinner blood glucose levels due to different snacks in healthy adults between the ages of 18 and 59 years, using four different snacking interventions, including no snack at 5 p.m.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Blood glucose IAUC value 5 hours after dinner

Key secondary outcomes

Highest blood glucose level after dinner, blood glucose IAUC level 2 hours after snack, highest blood glucose level, appetite, concentration, fatigue, subjective assessment of sleep, objective assessment of sleep, free fatty acids in blood, gut flora


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

no snack

Interventions/Control_2

Snack of Fruit Foods

Interventions/Control_3

cookie

Interventions/Control_4

rice cookie

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

59 years-old >=

Gender

Male and Female

Key inclusion criteria

(i) Healthy adults between the ages of 18 and 59 years old at the time of obtaining consent.
(ii) A person who is able to participate in the specified research period and visit the laboratory on the specified date
(iii) A person who can download the smartphone application to his/her own cell phone and use it.

Key exclusion criteria

(i) Those whose usual eating and sleeping habits are extremely irregular (including those who work night shifts or shift work)
(ii) Those who regularly use sleeping pills, sleeping supplements, or drugs or supplements that affect blood glucose levels
(iii) Those who are participating or will participate in other clinical studies
(iv) Those who plan to travel to time zones during the study period and two weeks prior to the start of the study.
(v) Those who are using an implantable medical device such as a pacemaker (vi) Those who are eating the following foods (milk, eggs, and rice)
(vi) Those who are allergic to the following foods (milk, egg, wheat, soybean, beef, mackerel, chicken, pork, apple, gelatin)

Target sample size

23


Research contact person

Name of lead principal investigator

1st name Yu
Middle name
Last name Tahara

Organization

Hiroshima University

Division name

Graduate School of Biomedical and Health Sciences

Zip code

734-0037

Address

Hiroshima-shi Kasumi 1-2-3, Hiroshima

TEL

082-257-5167

Email

yutahara@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Yu
Middle name
Last name Tahara

Organization

Hiroshima University

Division name

Graduate School of Biomedical and Health Sciences

Zip code

734-0037

Address

Hiroshima-shi Kasumi 1-2-3, Hiroshima

TEL

082-257-5167

Homepage URL


Email

yutahara@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University

Institute

Department

Personal name



Funding Source

Organization

AOHATA Corporation, Kewpie Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee for Clinical Research of Hiroshima University

Address

Kasumi 1-2-3, Hiroshima-shi, Hiroshima

Tel

082-257-1551

Email

iryo-sinsa@office.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

広島大学


Other administrative information

Date of disclosure of the study information

2025 Year 05 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 05 Month 06 Day

Date of IRB


Anticipated trial start date

2025 Year 07 Month 01 Day

Last follow-up date

2026 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 05 Month 10 Day

Last modified on

2025 Year 05 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066101